Monday 11 July 2016

Clinical Diagnostics Market Analysis, Size and Growth to 2022

Development of sophisticated and specialized tests for early disease detection and disease management and increasing demand for lab automation are the key drivers of clinical diagnostics market. The rapidly rising use of point of care diagnostic products has introduced a decentralization trend in the healthcare industry. Patients and healthcare facilities in an attempt to encourage early diagnosis, to cater medical facilities remotely and curb costs are now decentralizing their facilities. A wide array of clinical tests facilitate healthcare specialists the ability to detect disease progression which also include blood and urine test ranging from simple to complex, molecular expression genetic analysis and various medical chemistry panels.

For more information on "Clinical Diagnostics Market Analysis” 

The global laboratory test market is expected to grow at a lucrative rate through the forecast period. Diagnostics market is segmented into clinical laboratory testing market and point-of-care testing. There are more than 4,000 different diagnostic tests available today and have been divided into lipid panel, complete blood count, HbA1c tests, HGB/HCT, BUN creatinine, liver panel, electrolytes testing, basic and comprehensive metabolic and renal panel tests. Lipid panel test is anticipated to be the fasted growing segment due to high prevalence of obesity and cholesterol related disease. Point of care diagnostics market is expected to show a significant growth rate during the forecast period owing to the growing geriatric population base, the ability of point of care diagnostic tests to render immediate results and hence improved patient care and rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records). 

Global clinical diagnostic laboratory testing market is segmented into four major regions namely North America, Europe, Asia Pacific, Latin America and MEA. North America held the largest market share in terms of revenue owing to  increasing geriatric population base, rising patient awareness towards value of laboratory tests, availability of cost effective diagnostic tests related to chronic diseases such as AIDS and hepatitis C. Growing demand for the healthcare services in emerging markets and the presence of high unmet clinical testing needs have resulted in development of lucrative opportunities for growth of laboratory testing market in emerging economies such as China and India.

Request TOC of “Clinical Diagnostics Market Analysis" 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com

1 comment: